Skip to main content

depression treatment

data-content-type="article"

FDA allows treatment of depression with club drug's cousin

March 06, 2019 12:00 AM
This photo provided by Janssen Global Services shows Spravato nasal spray. Spravato, a mind-altering medication related to the club drug Special K, won U.S. approval Tuesday, March 5, for patients with hard-to-treat depression, the first in a series of long-overlooked substances being reconsidered for severe forms of mental illness. (Janssen Global Services via AP)
overrideBackgroundColorOrImage= overrideTextColor= overrideTextAlignment= overrideCardHideSection= overrideCardHideByline= overrideCardHideDescription= overridebuttonBgColor= overrideButtonText= overrideTextAlignment=